Sarah Cavanaugh
Senior Vice President
Corporate Affairs and Administration
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.
© 2021 Celldex Therapeutics, All rights reserved | Site Map | Privacy Policy | Terms of Use | Contact
